Alyssa Sheffield
Baytown, TXNPI 1326704537
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,724 of the $5,753 with a category attached, or 82.1%. It is spread thinly across 42 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations.
Across 232 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$571
- AstraZeneca$502
- E.r. Squibb & Sons, L.L.C.$364
- Sobi, Inc$351
- Astellas Pharma US Inc$347
- Seagen Inc.$347
- plus $3K from 36 others
What the payments were for
- Food & beverage$4,72482%
- Education$1,02918%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $158 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.